 | • レポートコード：GIR-105X12876 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、眼科用医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。眼科用医薬品の種類別市場規模（抗アレルギー、抗VEGF剤、抗炎症、抗緑内障）、用途別市場規模（病院、クリニック、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・眼科用医薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Santen Pharmaceutical、Bausch Health、Takeda、Novartis、Genentech、Allergan、Sun Pharmaceutical Industries、Actavis Generics、Regeneron Pharmaceuticals、Pfizer、Johnson and Johnson、Bausch and Lomb ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：抗アレルギー、抗VEGF剤、抗炎症、抗緑内障 ・用途別分析2016年-2026年：病院、クリニック、薬局 ・眼科用医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・眼科用医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・眼科用医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・眼科用医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・眼科用医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Ophthalmic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Ophthalmic Drugs size is estimated to be xx million in 2021 from USD 22950 million in 2020, with a change of XX% between 2020 and 2021. The global Ophthalmic Drugs market size is expected to grow at a CAGR of 2.2% for the next five years.
Market segmentation
Ophthalmic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Market segment by Application can be divided into
Hospital
Clinic
Pharmacy
The key market players for global Ophthalmic Drugs market are listed below:
Santen Pharmaceutical
Bausch Health
Takeda
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Ophthalmic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ophthalmic Drugs, with price, sales, revenue and global market share of Ophthalmic Drugs from 2019 to 2021.
Chapter 3, the Ophthalmic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Ophthalmic Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Ophthalmic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Ophthalmic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ophthalmic Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Anti-allergy
1.2.3 Anti-VEGF Agents
1.2.4 Anti-inflammatory
1.2.5 Anti-glaucoma
1.3 Market Analysis by Application
1.3.1 Overview: Global Ophthalmic Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Ophthalmic Drugs Market Size & Forecast
1.4.1 Global Ophthalmic Drugs Sales in Value (2016-2026))
1.4.2 Global Ophthalmic Drugs Sales in Volume (2016-2026)
1.4.3 Global Ophthalmic Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Ophthalmic Drugs Production Capacity Analysis
1.5.1 Global Ophthalmic Drugs Total Production Capacity (2016-2026)
1.5.2 Global Ophthalmic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ophthalmic Drugs Market Drivers
1.6.2 Ophthalmic Drugs Market Restraints
1.6.3 Ophthalmic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Santen Pharmaceutical
2.1.1 Santen Pharmaceutical Details
2.1.2 Santen Pharmaceutical Major Business
2.1.3 Santen Pharmaceutical Ophthalmic Drugs Product and Services
2.1.4 Santen Pharmaceutical Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bausch Health
2.2.1 Bausch Health Details
2.2.2 Bausch Health Major Business
2.2.3 Bausch Health Ophthalmic Drugs Product and Services
2.2.4 Bausch Health Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Ophthalmic Drugs Product and Services
2.3.4 Takeda Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Ophthalmic Drugs Product and Services
2.4.4 Novartis Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Genentech
2.5.1 Genentech Details
2.5.2 Genentech Major Business
2.5.3 Genentech Ophthalmic Drugs Product and Services
2.5.4 Genentech Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Ophthalmic Drugs Product and Services
2.6.4 Allergan Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Sun Pharmaceutical Industries
2.7.1 Sun Pharmaceutical Industries Details
2.7.2 Sun Pharmaceutical Industries Major Business
2.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Product and Services
2.7.4 Sun Pharmaceutical Industries Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Actavis Generics
2.8.1 Actavis Generics Details
2.8.2 Actavis Generics Major Business
2.8.3 Actavis Generics Ophthalmic Drugs Product and Services
2.8.4 Actavis Generics Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Regeneron Pharmaceuticals
2.9.1 Regeneron Pharmaceuticals Details
2.9.2 Regeneron Pharmaceuticals Major Business
2.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Product and Services
2.9.4 Regeneron Pharmaceuticals Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Ophthalmic Drugs Product and Services
2.10.4 Pfizer Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Johnson and Johnson
2.11.1 Johnson and Johnson Details
2.11.2 Johnson and Johnson Major Business
2.11.3 Johnson and Johnson Ophthalmic Drugs Product and Services
2.11.4 Johnson and Johnson Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Bausch and Lomb
2.12.1 Bausch and Lomb Details
2.12.2 Bausch and Lomb Major Business
2.12.3 Bausch and Lomb Ophthalmic Drugs Product and Services
2.12.4 Bausch and Lomb Ophthalmic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Ophthalmic Drugs Sales by Manufacturer
3.1 Global Ophthalmic Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Ophthalmic Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Ophthalmic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Ophthalmic Drugs Manufacturer Market Share
3.4.2 Top 6 Ophthalmic Drugs Manufacturer Market Share
3.5 Global Ophthalmic Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Ophthalmic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ophthalmic Drugs Market Size by Region
4.1.1 Global Ophthalmic Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Ophthalmic Drugs Revenue by Region (2016-2026)
4.2 North America Ophthalmic Drugs Revenue (2016-2026)
4.3 Europe Ophthalmic Drugs Revenue (2016-2026)
4.4 Asia-Pacific Ophthalmic Drugs Revenue (2016-2026)
4.5 South America Ophthalmic Drugs Revenue (2016-2026)
4.6 Middle East and Africa Ophthalmic Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Ophthalmic Drugs Sales in Volume by Type (2016-2026)
5.2 Global Ophthalmic Drugs Revenue by Type (2016-2026)
5.3 Global Ophthalmic Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Ophthalmic Drugs Sales in Volume by Application (2016-2026)
6.2 Global Ophthalmic Drugs Revenue by Application (2016-2026)
6.3 Global Ophthalmic Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Ophthalmic Drugs Sales by Type (2016-2026)
7.2 North America Ophthalmic Drugs Sales by Application (2016-2026)
7.3 North America Ophthalmic Drugs Market Size by Country
7.3.1 North America Ophthalmic Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Ophthalmic Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Ophthalmic Drugs Sales by Type (2016-2026)
8.2 Europe Ophthalmic Drugs Sales by Application (2016-2026)
8.3 Europe Ophthalmic Drugs Market Size by Country
8.3.1 Europe Ophthalmic Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Ophthalmic Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Ophthalmic Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Ophthalmic Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Ophthalmic Drugs Market Size by Region
9.3.1 Asia-Pacific Ophthalmic Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Ophthalmic Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Ophthalmic Drugs Sales by Type (2016-2026)
10.2 South America Ophthalmic Drugs Sales by Application (2016-2026)
10.3 South America Ophthalmic Drugs Market Size by Country
10.3.1 South America Ophthalmic Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Ophthalmic Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ophthalmic Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Ophthalmic Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Ophthalmic Drugs Market Size by Country
11.3.1 Middle East & Africa Ophthalmic Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Ophthalmic Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Ophthalmic Drugs Typical Distributors
12.3 Ophthalmic Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Ophthalmic Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Ophthalmic Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Santen Pharmaceutical Major Business
Table 5. Santen Pharmaceutical Ophthalmic Drugs Product and Services
Table 6. Santen Pharmaceutical Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 8. Bausch Health Major Business
Table 9. Bausch Health Ophthalmic Drugs Product and Services
Table 10. Bausch Health Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Takeda Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Major Business
Table 13. Takeda Ophthalmic Drugs Product and Services
Table 14. Takeda Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Ophthalmic Drugs Product and Services
Table 18. Novartis Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Genentech Basic Information, Manufacturing Base and Competitors
Table 20. Genentech Major Business
Table 21. Genentech Ophthalmic Drugs Product and Services
Table 22. Genentech Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Allergan Basic Information, Manufacturing Base and Competitors
Table 24. Allergan Major Business
Table 25. Allergan Ophthalmic Drugs Product and Services
Table 26. Allergan Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 28. Sun Pharmaceutical Industries Major Business
Table 29. Sun Pharmaceutical Industries Ophthalmic Drugs Product and Services
Table 30. Sun Pharmaceutical Industries Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Actavis Generics Basic Information, Manufacturing Base and Competitors
Table 32. Actavis Generics Major Business
Table 33. Actavis Generics Ophthalmic Drugs Product and Services
Table 34. Actavis Generics Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Regeneron Pharmaceuticals Major Business
Table 37. Regeneron Pharmaceuticals Ophthalmic Drugs Product and Services
Table 38. Regeneron Pharmaceuticals Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Pfizer Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Ophthalmic Drugs Product and Services
Table 42. Pfizer Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson and Johnson Major Business
Table 45. Johnson and Johnson Ophthalmic Drugs Product and Services
Table 46. Johnson and Johnson Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Bausch and Lomb Basic Information, Manufacturing Base and Competitors
Table 48. Bausch and Lomb Major Business
Table 49. Bausch and Lomb Ophthalmic Drugs Product and Services
Table 50. Bausch and Lomb Ophthalmic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Ophthalmic Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 52. Global Ophthalmic Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Ophthalmic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Ophthalmic Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 55. Head Office and Ophthalmic Drugs Production Site of Key Manufacturer
Table 56. Ophthalmic Drugs New Entrant and Capacity Expansion Plans
Table 57. Ophthalmic Drugs Mergers & Acquisitions in the Past Five Years
Table 58. Global Ophthalmic Drugs Sales by Region (2016-2021e) & (K MT)
Table 59. Global Ophthalmic Drugs Sales by Region (2021-2026) & (K MT)
Table 60. Global Ophthalmic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Ophthalmic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Ophthalmic Drugs Sales by Type (2016-2021e) & (K MT)
Table 63. Global Ophthalmic Drugs Sales by Type (2021-2026) & (K MT)
Table 64. Global Ophthalmic Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Ophthalmic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Ophthalmic Drugs Price by Type (2016-2021e) & (USD/MT)
Table 67. Global Ophthalmic Drugs Price by Type (2021-2026) & (USD/MT)
Table 68. Global Ophthalmic Drugs Sales by Application (2016-2021e) & (K MT)
Table 69. Global Ophthalmic Drugs Sales by Application (2021-2026) & (K MT)
Table 70. Global Ophthalmic Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Ophthalmic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Ophthalmic Drugs Price by Application (2016-2021e) & (USD/MT)
Table 73. Global Ophthalmic Drugs Price by Application (2021-2026) & (USD/MT)
Table 74. North America Ophthalmic Drugs Sales by Country (2016-2021e) & (K MT)
Table 75. North America Ophthalmic Drugs Sales by Country (2021-2026) & (K MT)
Table 76. North America Ophthalmic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Ophthalmic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Ophthalmic Drugs Sales by Type (2016-2021e) & (K MT)
Table 79. North America Ophthalmic Drugs Sales by Type (2021-2026) & (K MT)
Table 80. North America Ophthalmic Drugs Sales by Application (2016-2021e) & (K MT)
Table 81. North America Ophthalmic Drugs Sales by Application (2021-2026) & (K MT)
Table 82. Europe Ophthalmic Drugs Sales by Country (2016-2021e) & (K MT)
Table 83. Europe Ophthalmic Drugs Sales by Country (2021-2026) & (K MT)
Table 84. Europe Ophthalmic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Ophthalmic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Ophthalmic Drugs Sales by Type (2016-2021e) & (K MT)
Table 87. Europe Ophthalmic Drugs Sales by Type (2021-2026) & (K MT)
Table 88. Europe Ophthalmic Drugs Sales by Application (2016-2021e) & (K MT)
Table 89. Europe Ophthalmic Drugs Sales by Application (2021-2026) & (K MT)
Table 90. Asia-Pacific Ophthalmic Drugs Sales by Region (2016-2021e) & (K MT)
Table 91. Asia-Pacific Ophthalmic Drugs Sales by Region (2021-2026) & (K MT)
Table 92. Asia-Pacific Ophthalmic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Ophthalmic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Ophthalmic Drugs Sales by Type (2016-2021e) & (K MT)
Table 95. Asia-Pacific Ophthalmic Drugs Sales by Type (2021-2026) & (K MT)
Table 96. Asia-Pacific Ophthalmic Drugs Sales by Application (2016-2021e) & (K MT)
Table 97. Asia-Pacific Ophthalmic Drugs Sales by Application (2021-2026) & (K MT)
Table 98. South America Ophthalmic Drugs Sales by Country (2016-2021e) & (K MT)
Table 99. South America Ophthalmic Drugs Sales by Country (2021-2026) & (K MT)
Table 100. South America Ophthalmic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Ophthalmic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Ophthalmic Drugs Sales by Type (2016-2021e) & (K MT)
Table 103. South America Ophthalmic Drugs Sales by Type (2021-2026) & (K MT)
Table 104. South America Ophthalmic Drugs Sales by Application (2016-2021e) & (K MT)
Table 105. South America Ophthalmic Drugs Sales by Application (2021-2026) & (K MT)
Table 106. Middle East & Africa Ophthalmic Drugs Sales by Country (2016-2021e) & (K MT)
Table 107. Middle East & Africa Ophthalmic Drugs Sales by Country (2021-2026) & (K MT)
Table 108. Middle East & Africa Ophthalmic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Ophthalmic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Ophthalmic Drugs Sales by Type (2016-2021e) & (K MT)
Table 111. Middle East & Africa Ophthalmic Drugs Sales by Type (2021-2026) & (K MT)
Table 112. Middle East & Africa Ophthalmic Drugs Sales by Application (2016-2021e) & (K MT)
Table 113. Middle East & Africa Ophthalmic Drugs Sales by Application (2021-2026) & (K MT)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Ophthalmic Drugs Typical Distributors
Table 117. Ophthalmic Drugs Typical Customers
List of Figures
Figure 1. Ophthalmic Drugs Picture
Figure 2. Global Ophthalmic Drugs Sales Market Share by Type in 2020
Figure 3. Anti-allergy
Figure 4. Anti-VEGF Agents
Figure 5. Anti-inflammatory
Figure 6. Anti-glaucoma
Figure 7. Global Ophthalmic Drugs Sales Market Share by Application in 2020
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Pharmacy
Figure 11. Global Ophthalmic Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 12. Global Ophthalmic Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Ophthalmic Drugs Sales (2016-2026) & (K MT)
Figure 14. Global Ophthalmic Drugs Price by Type (2016-2026) & (USD/MT)
Figure 15. Global Ophthalmic Drugs Production Capacity (2016-2026) & (K MT)
Figure 16. Global Ophthalmic Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Ophthalmic Drugs Market Drivers
Figure 18. Ophthalmic Drugs Market Restraints
Figure 19. Ophthalmic Drugs Market Trends
Figure 20. Global Ophthalmic Drugs Sales Market Share by Manufacturer in 2020
Figure 21. Global Ophthalmic Drugs Revenue Market Share by Manufacturer in 2020
Figure 22. Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Ophthalmic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Ophthalmic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Ophthalmic Drugs Sales Market Share by Region (2016-2026)
Figure 26. Global Ophthalmic Drugs Revenue Market Share by Region (2016-2026)
Figure 27. North America Ophthalmic Drugs Revenue (2016-2026) & (USD Million)
Figure 28. Europe Ophthalmic Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Ophthalmic Drugs Revenue (2016-2026) & (USD Million)
Figure 30. South America Ophthalmic Drugs Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Ophthalmic Drugs Revenue (2016-2026) & (USD Million)
Figure 32. Global Ophthalmic Drugs Sales Market Share by Type (2016-2026)
Figure 33. Global Ophthalmic Drugs Revenue Market Share by Type (2016-2026)
Figure 34. Global Ophthalmic Drugs Price by Type (2016-2026) & (USD/MT)
Figure 35. Global Ophthalmic Drugs Sales Market Share by Application (2016-2026)
Figure 36. Global Ophthalmic Drugs Revenue Market Share by Application (2016-2026)
Figure 37. Global Ophthalmic Drugs Price by Application (2016-2026) & (USD/MT)
Figure 38. North America Ophthalmic Drugs Sales Market Share by Type (2016-2026)
Figure 39. North America Ophthalmic Drugs Sales Market Share by Application (2016-2026)
Figure 40. North America Ophthalmic Drugs Sales Market Share by Country (2016-2026)
Figure 41. North America Ophthalmic Drugs Revenue Market Share by Country (2016-2026)
Figure 42. United States Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Ophthalmic Drugs Sales Market Share by Type (2016-2026)
Figure 46. Europe Ophthalmic Drugs Sales Market Share by Application (2016-2026)
Figure 47. Europe Ophthalmic Drugs Sales Market Share by Country (2016-2026)
Figure 48. Europe Ophthalmic Drugs Revenue Market Share by Country (2016-2026)
Figure 49. Germany Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Ophthalmic Drugs Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Ophthalmic Drugs Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Ophthalmic Drugs Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Ophthalmic Drugs Revenue Market Share by Region (2016-2026)
Figure 58. China Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Ophthalmic Drugs Sales Market Share by Type (2016-2026)
Figure 65. South America Ophthalmic Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Ophthalmic Drugs Sales Market Share by Country (2016-2026)
Figure 67. South America Ophthalmic Drugs Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Ophthalmic Drugs Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Ophthalmic Drugs Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Ophthalmic Drugs Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Ophthalmic Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Ophthalmic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
眼科用医薬品の世界市場2018-2025 Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disor…- 世界の抗にきび薬市場 2021：企業別、地域別、種類・用途別 The Anti Acne Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
- 世界の抗片頭痛薬市場 2021：企業別、地域別、種類・用途別 The Anti-Migraine Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 点眼液の世界市場2018-2025 In 2018, the global Ophthalmic Solution market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Ophthalmic Solution. This study …
- 抗肥満薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain diet…